Leeling J, Kowalski T
Arzneimittelforschung. 1976;26(9):1668-70.
The biological disposition of 1-methyl-3-keto-phenylquinuclidinium bromide (MA540) has been studied in the rat and dog. Gastrointestinal absorption of the drug was considerably different in the 2 species; about 15% and 75% of the dose in the rat and dog, respectively. Tissue distribution after i.v. administration was characterized by generally high tissue/plasma drug ratios in the rat and by low plasma (the only tissue examined) levels in the dog. Drug localization was apparent in the liver and adrenals, and the highest average (24-h) concentration was found in those tissues. The distribution profile and the chemical nature of MA540 suggest that the compound was distributed, at least initially, in extracellular water. MA540 was not extensively metabolized by either species. Excretion, although initially fairly rapid, slowed such that whole body half-lives were estimated to be 21 h and 47 h in the rat and dog, respectively.
对1-甲基-3-酮基-苯基喹核溴化物(MA540)在大鼠和犬体内的生物学特性进行了研究。该药物在这两个物种中的胃肠道吸收情况有很大差异;在大鼠和犬体内,分别约有15%和75%的剂量被吸收。静脉注射给药后的组织分布特点是,在大鼠体内组织/血浆药物比率普遍较高,而在犬体内血浆(唯一检测的组织)水平较低。药物在肝脏和肾上腺中明显聚集,且在这些组织中发现了最高的平均(24小时)浓度。MA540的分布情况和化学性质表明,该化合物至少在最初是分布在细胞外液中的。MA540在这两个物种中均未发生广泛代谢。排泄虽然最初相当迅速,但后来减缓,估计大鼠和犬的全身半衰期分别为21小时和47小时。